ASB9 Polyclonal antibody
ASB9 Polyclonal Antibody for WB, IHC, ELISA
Host / Isotype
Rabbit / IgG
Reactivity
human
Applications
WB, IHC, ELISA
Conjugate
Unconjugated
Cat no : 11952-1-AP
Synonyms
Validation Data Gallery
Tested Applications
Positive WB detected in | human testis tissue, HepG2 cells |
Positive IHC detected in | human stomach cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:500-1:1000 |
Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
Published Applications
IHC | See 1 publications below |
Product Information
11952-1-AP targets ASB9 in WB, IHC, ELISA applications and shows reactivity with human samples.
Tested Reactivity | human |
Cited Reactivity | human |
Host / Isotype | Rabbit / IgG |
Class | Polyclonal |
Type | Antibody |
Immunogen | ASB9 fusion protein Ag2554 |
Full Name | ankyrin repeat and SOCS box-containing 9 |
Calculated Molecular Weight | 252 aa, 28 kDa, 32 kDa |
Observed Molecular Weight | 28-32 kDa |
GenBank Accession Number | BC001244 |
Gene Symbol | ASB9 |
Gene ID (NCBI) | 140462 |
RRID | AB_10666996 |
Conjugate | Unconjugated |
Form | Liquid |
Purification Method | Antigen affinity purification |
Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol pH 7.3. |
Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
Product Specific Protocols | |
---|---|
WB protocol for ASB9 antibody 11952-1-AP | Download protocol |
IHC protocol for ASB9 antibody 11952-1-AP | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
Publications
Species | Application | Title |
---|---|---|
Molecules Identification of Key Candidate Genes Involved in the Progression of Idiopathic Pulmonary Fibrosis. | ||
Oncol Rep HMQ‑T‑F2 suppresses migration of the human cervical cancer HeLa cells by reversing EMT via the PI3K/Akt signaling pathway. |